McDonald’s has become the latest fast food chain to try to adapt to the rise of Americans on weight-loss drugs — and is teasing new, protein-rich menu items.
CEO Chris Kempczinski said during an earnings call last Wednesday that McDonald’s is testing menu items to appeal to its customers who are taking GLP-1 medications such as Ozempic and Wegovy, who prefer more protein-packed meals, according to Benzinga.